发明名称 |
BACTERIOPHAGE THERAPY. |
摘要 |
The subject invention provides a pharmaceutical composition comprising: (i) at least one bacteriophage strain(s) capable of producing a lytic infection in an adherent- invasive <i>Escherichia coli</i> strain; and (ii) a pharmaceutically acceptable carrier; for the treatment of inflammatory bowel disease. The subject invention further provides a method of treating inflammatory bowel disease comprising administering to a subject in need thereof at least one bacteriophage strain capable of producing a lytic infection in an adherent-invasive <i>Escherichia coli</i> strain thereby treating the subject. The subject invention also provides new bacteriophage strains. |
申请公布号 |
MX2015015092(A) |
申请公布日期 |
2016.06.07 |
申请号 |
MX20150015092 |
申请日期 |
2014.04.30 |
申请人 |
FERRING B.V. |
发明人 |
DANGLAS, PASCAL;DEBARBIEUX, LAURENT |
分类号 |
A61K9/20;A61K35/76;A61K47/48;A61P1/12 |
主分类号 |
A61K9/20 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|